Avient
AVNT · Specialty Chemicals
$41.03
1.1%H.B. Fuller
FUL · Specialty Chemicals
$49.61
2.5%The short version
- H.B. Fuller is the larger business, with $3.5B of revenue in fiscal 2025 against $3.3B for Avient.
- Avient grew revenue faster (0.6%, against −2.7%).
- Avient turned more of its sales into free cash flow (6.0% FCF margin, against 3.5% FCF margin).
- H.B. Fuller earned a higher return on the capital invested in it (6.3%, against 4.0%).
- Investors pay more for each dollar of Avient’s earnings: a P/E of 22.2x against 13.8x for H.B. Fuller.
| Latest fiscal year | AVNT · FY25 | FUL · FY25 |
|---|---|---|
| Size | ||
| Market cap | $3.8B | $2.7B |
| Revenue | $3.3B | $3.5B |
| Free cash flow | $195M | $121M |
| Net income | $81.9M | $152M |
| Growth | ||
| Revenue growth | 0.6% | −2.7% |
| 5-year growth | 8.0% | 4.5% |
| Share count change | −0.2% | −2.3% |
| Profitability | ||
| Gross margin | 31.2% | 31.1% |
| Operating margin | 6.2% | — |
| Net margin | 2.5% | 4.4% |
| FCF margin | 6.0% | 3.5% |
| Return on capital | 4.0% | 6.3% |
| Return on equity | 3.5% | 7.9% |
| Balance sheet | ||
| Net debt | $1.4B | $1.9B |
| Net debt / EBITDA | 3.6x | 3.6x |
| Dividends and buybacks | $98.8M | $111M |
| Valuation & quality | ||
| P/E | 22.2x | 13.8x |
| Piotroski F-score | 6 | 7 |
FY16
AVNT $2.9B
FUL $2.1B
FY17
AVNT $2.6B
FUL $2.3B
FY18
AVNT $2.9B
FUL $3.0B
FY19
AVNT $2.9B
FUL $2.9B
FY20
AVNT $2.2B
FUL $2.8B
FY21
AVNT $3.3B
FUL $3.3B
FY22
AVNT $3.4B
FUL $3.7B
FY23
AVNT $3.1B
FUL $3.5B
FY24
AVNT $3.2B
FUL $3.6B
FY25
AVNT $3.3B
FUL $3.5B
AVNT
FUL
FY16
AVNT 9.1%
FUL 9.5%
FY17
AVNT 6.7%
FUL 5.2%
FY18
AVNT 6.2%
FUL 7.8%
FY19
AVNT 5.5%
FUL 7.8%
FY20
AVNT 5.0%
FUL 7.8%
FY21
AVNT 8.4%
FUL 7.7%
FY22
AVNT 7.2%
FUL 8.6%
FY23
AVNT 6.3%
FUL 10.1%
FY24
AVNT 10.2%
FUL 9.8%
FY25
AVNT 6.2%
FUL —
AVNT
FUL
FY16
AVNT $143M
FUL $132M
FY17
AVNT $123M
FUL $111M
FY18
AVNT $178M
FUL $185M
FY19
AVNT $219M
FUL $207M
FY20
AVNT $158M
FUL $244M
FY21
AVNT $133M
FUL $117M
FY22
AVNT $293M
FUL $127M
FY23
AVNT $82.2M
FUL $259M
FY24
AVNT $135M
FUL $163M
FY25
AVNT $195M
FUL $121M
AVNT
FUL
FY16
AVNT 11.8%
FUL 9.5%
FY17
AVNT 10.1%
FUL 4.2%
FY18
AVNT 9.1%
FUL 7.3%
FY19
AVNT 6.9%
FUL 5.1%
FY20
AVNT 5.1%
FUL 5.1%
FY21
AVNT 7.0%
FUL 5.6%
FY22
AVNT 7.0%
FUL 7.0%
FY23
AVNT 4.4%
FUL 6.4%
FY24
AVNT 6.5%
FUL 6.8%
FY25
AVNT 4.0%
FUL 6.3%
AVNT
FUL
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.